INTANGIBLE ASSETS	6 Months Ended
Jun. 30, 2011
INTANGIBLE ASSETS	NOTE 5 - INTANGIBLE ASSETS At June 30, 2011 and December 31, 2010, intangible assets consisted of customers’ lists arising from the acquisition of Likang Biological, amortized over 5 years. Net intangible assets as of June 30, 2011 and December 31, 2010 totaled $359,554 and $410,918, respectively. Amortization expenses for the six months ended June 30, 2011 and 2010 were $51,365 and $51,365, respectively. Amortization expenses for the three months ended June 30, 2011 and 2010 were 25,682 and $25,682. Annual amortization expenses for the next five years from June 30, 2011 are expected to be: $102,730, $102,730, $102,730, $51,363 and $0.

INTANGIBLE ASSETS

6 Months Ended

Jun. 30, 2011

NOTE 5 - INTANGIBLE ASSETS

At June 30, 2011 and December 31, 2010, intangible assets consisted of customers’ lists arising from the acquisition of Likang Biological, amortized over 5 years. Net intangible assets as of June 30, 2011 and December 31, 2010 totaled $359,554 and $410,918, respectively. Amortization expenses for the six months ended June 30, 2011 and 2010 were $51,365 and $51,365, respectively. Amortization expenses for the three months ended June 30, 2011 and 2010 were 25,682 and $25,682. Annual amortization expenses for the next five years from June 30, 2011 are expected to be: $102,730, $102,730, $102,730, $51,363 and $0.